Wachtell, Lipton, Rosen & Katz acted as special counsel to Regeneron Pharmaceuticals, Inc., while Ropes & Gray represented the lead underwriters in the offering. Regeneron Pharmaceuticals…
Regeneron Pharmaceuticals’ $7 Billion Secondary Offering and $5 Billion Share Repurchase
